Cytosorbents Corporation
看多

Too cheap

53
This is trading around $10 as i speak. I understand that the by making a public offering has mad some investors a little angry but has undoubtedly created opportunity for new investors to join in. they have made a Preliminary Q2 announcement: 58% increase in revenue from Q2 2019. The list of accomplishment for Q2 is very good.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。